随着特朗普计划美国药物关税并刺激国内制造业,印度的药厂库存急剧下降。 Pharma stocks in India plummet as Trump plans U.S. drug tariffs and boosts domestic manufacturing.

印度制药股周二受到了冲击, 尼夫蒂制药指数下跌1. 8%, 原因是特朗普总统下令推动美国国内制药生产, 并宣布对药品征收关税. Pharma stocks in India took a hit on Tuesday, with the Nifty Pharma Index dropping 1.8%, following President Trump's executive orders to boost domestic drug manufacturing in the U.S. and his plan to announce pharmaceutical tariffs. Aurobindo、Cipla和Lupin等关键公司由于严重依赖美国市场而大幅下降。 Key companies like Aurobindo, Cipla, and Lupin saw significant declines as they rely heavily on the U.S. market. 行政命令旨在通过加速批准和鼓励国内生产来减少美国对外国制造药品的依赖。 The executive orders aim to reduce the U.S.'s dependence on foreign-made medicines by accelerating approvals and encouraging domestic production.